MPCheck, a healthcare technology company, has announced that it has signed a contract with Teva Pharmaceuticals, a global pharmaceutical company. Under the terms of the agreement, Teva Pharmaceuticals’ employees will now be able to undergo periodic screening tests in the workplace, making it more convenient and efficient for them.
According to MPCheck, preventive medicine is the key to saving lives. By providing a screening service at the workplace, employees can take charge of their health without disrupting their daily routine. This innovative and advanced service will be available to them right where they work.
In the past, employees had to take time off work to go to various laboratories for half a day, but the development of technology has made it possible to create a more customer-friendly and convenient process. MPCheck CEO Nitzan Lahat commented on the partnership, stating, “We are happy that Teva Pharmaceuticals’ employees will also be able to perform periodic screening tests in the workplace, conveniently and quickly.”
This partnership between MPCheck and Teva Pharmaceuticals is a significant step towards creating a healthier workplace environment. By making it easier for employees to take care of their health, companies can improve employee morale, reduce absenteeism, and increase productivity.
In conclusion, this partnership is a win-win for both companies and their employees. It represents a new trend in healthcare that emphasizes the importance of prevention, early detection, and convenience. With MPCheck’s cutting-edge technology, employees can maintain their health while continuing to perform their job duties with ease.
